期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Application of Clinical Nursing Pathway in the Peri-Treatment Period of Immunoadsorption Therapy for Rheumatic Immune Diseases
1
作者 Li Wang Fan Fan Yanrui Ren 《Yangtze Medicine》 2023年第2期87-94,共8页
Objective: The paper aims to investigate the clinical nursing pathway (CNP) in the application of immunosorption therapy in patients with rheumatic immune disease. Methods: Convenience sampling method was used to sele... Objective: The paper aims to investigate the clinical nursing pathway (CNP) in the application of immunosorption therapy in patients with rheumatic immune disease. Methods: Convenience sampling method was used to select inpatients who received immunoadsorption therapy from January 2020 to December 2022 in the rheumatology and Immunology department of a 3A hospital in Jingzhou City. 30 patients from January 2020 to June 2021 were selected as control group, and 30 patients from July 2021 to December 2022 were selected as observation group. The control group was given routine nursing. On the basis of the control group, the observation group used a clinical nursing pathway for intervention during the perioperative period of immunosorbent therapy. The incidence of adverse reactions, patient satisfaction, and nurse satisfaction during immunosorbent therapy between the control group and the observation group were compared. Results: After intervention, the incidence of adverse reactions in the observation group was significantly lower than that in the control group, while patient satisfaction and nurse satisfaction in the observation group were significantly higher than those in the control group. The results are all statistically significant (P Conclusion: Clinical nursing pathway is beneficial to reduce the incidence of adverse reactions in patients with immunoadsorption during peri-treatment and improve the satisfaction of patients and nurses. 展开更多
关键词 IMMUNOADSORPTION Clinical Nursing Pathway Rheumatic immune disease Peri-Treatment Period
下载PDF
Solitary necrotic nodules of the liver with"ring"-like calcification:A case report
2
作者 Jin-Peng Bao Hu Tian +2 位作者 Hao-Chen Wang Cong-Cong Wang Bo Li 《World Journal of Clinical Cases》 SCIE 2022年第21期7409-7414,共6页
BACKGROUND Solitary necrotic nodule of the liver(SNNL)is a rare benign lesion with a complete necrotic core and a clear fibrous capsule containing elastic fibers.We present the case of a patient with a radiographic co... BACKGROUND Solitary necrotic nodule of the liver(SNNL)is a rare benign lesion with a complete necrotic core and a clear fibrous capsule containing elastic fibers.We present the case of a patient with a radiographic computed tomography(CT)finding of"ring"-like annular calcification within the lesion and postoperative pathologic diagnosis of necrotic nodules wrapped by dense fibers in liver tissue,as well as the patient's subsequent management and outcome.CASE SUMMARY A 38-year-old Chinese woman with a history of systemic lupus erythematosus treated with prednisone and hydroxychloroquine,without any symptoms,was found to have hepatic space-occupying lesions by imaging examination at a health examination.A subsequent CT scan suggested a space-occupying lesion of the liver with annular calcification,which was not defined to be benign or malignant.After that,a laparoscopic hepatic space-occupying resection was performed.The postoperative pathological diagnosis was necrotic nodules wrapped by dense fibers in the liver tissue,and the final diagnosis was SNNL.The patient had an uneventful postoperative recovery.CONCLUSION There is a"ring"-like calcification in SNNL.This patient had a history of systemic lupus erythematosus,without a history of parasite infection,trauma,or tumor.Therefore,whether the etiology and pathological changes of SNNL are related to rheumatic immune diseases remains to be investigated. 展开更多
关键词 Solitary necrotic nodules of the liver Annular calcification Rheumatic immune disease Laparoscopic hepatic space-occupying resection Case report
下载PDF
Expert Recommendation on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients with Chronic Liver Diseases,Tuberculosis or Rheumatoid Diseases
3
作者 Chinese Society of Infectious Diseases,Chinese Medical Association Chinese Society of Rheumatology,Chinese Medical Association +1 位作者 Taisheng Li Yan Zhao 《Infectious Diseases & Immunity》 2021年第3期137-143,共7页
The coronavirus disease 2019(COVID-19)caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has triggered a global pandemic.At present,vaccination is being promoted worldwide and has become an important... The coronavirus disease 2019(COVID-19)caused by severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has triggered a global pandemic.At present,vaccination is being promoted worldwide and has become an important measure to control the pandemic.People with chronic liver diseases,tuberculosis,and rheumatic diseases are at a high risk of infection with SARS-CoV-2 and have a tendency to develop severe illness.Thus,vaccination among this population should be considered a priority.After taking into account domestic and international evidence,established guidelines,and local expert opinions,the operating rules for COVID-19 vaccination in patients with chronic liver diseases,tuberculosis,and rheumatic diseases have been prepared to provide specific suggestions. 展开更多
关键词 COVID-19 VACCINE Chronic liver disease TUBERCULOSIS Rheumatic immune disease
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部